Literature DB >> 21562928

PPARα is regulated by miR-21 and miR-27b in human liver.

Katsuhiko Kida1, Miki Nakajima, Takuya Mohri, Yuki Oda, Shingo Takagi, Tatsuki Fukami, Tsuyoshi Yokoi.   

Abstract

PURPOSE: Peroxisome proliferator-activated receptor α (PPARα) is an important transcriptional factor that regulates genes encoding endo/xenobiotic enzymes and lipid metabolizing enzymes. In this study, we investigated whether microRNAs (miRNAs) are involved in the regulation of PPARα in human liver.
METHODS: Precursor or antisense oligonucleotide for miR-21 or miR-27b was transfected into HuH7 cells; expression of PPARα and acyl-CoA synthetase M2B was determined by Western blot and real-time RT-PCR. Luciferase assay was performed to identify the functional miRNA recognition element (MRE). Expression levels of PPARα, miR-21, and miR-27b in a panel of 24 human livers were determined.
RESULTS: The overexpression and inhibition of miR-21 or miR-27b in HuH7 cells significantly decreased and increased the PPARα protein level, respectively, but not PPARα mRNA level. The miRNA-dependent regulation of PPARα affected the expression of its downstream gene. Luciferase assay identified a functional MRE for miR-21 in the 3'-untranslated region of PPARα. In human livers, the PPARα protein levels were not correlated with PPARα mRNA, but inversely correlated with the miR-21 levels, suggesting a substantial impact of miR-21, although the contribution of miR-27b could not be ruled out.
CONCLUSIONS: We found that PPARα in human liver is regulated by miRNAs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562928     DOI: 10.1007/s11095-011-0473-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

Review 1.  Roles of PPARs in health and disease.

Authors:  S Kersten; B Desvergne; W Wahli
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

2.  Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation.

Authors:  Yatrik M Shah; Keiichirou Morimura; Qian Yang; Tomotaka Tanabe; Mitsuhiro Takagi; Frank J Gonzalez
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

3.  The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene.

Authors:  Olivier Barbier; Lyne Villeneuve; Virginie Bocher; Coralie Fontaine; Ines Pineda Torra; Christian Duhem; Vladimir Kosykh; Jean-Charles Fruchart; Chantal Guillemette; Bart Staels
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

Review 4.  Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future.

Authors:  Daniel H van Raalte; Min Li; P Haydn Pritchard; Kishor M Wasan
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

5.  The transcription of the peroxisome proliferator-activated receptor alpha gene is regulated by protein kinase C.

Authors:  N S Yaacob; M N Norazmi; G G Gibson; G E Kass
Journal:  Toxicol Lett       Date:  2001-12-15       Impact factor: 4.372

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

Authors:  Dennis Löffler; Katja Brocke-Heidrich; Gabriele Pfeifer; Claudia Stocsits; Jörg Hackermüller; Antje K Kretzschmar; Renate Burger; Martin Gramatzki; Conny Blumert; Kay Bauer; Helena Cvijic; A Kerstin Ullmann; Peter F Stadler; Friedemann Horn
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

8.  The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha.

Authors:  Christophe Blanquart; Roxane Mansouri; Réjane Paumelle; Jean-Charles Fruchart; Bart Staels; Corine Glineur
Journal:  Mol Endocrinol       Date:  2004-05-06

9.  MicroRNA regulates human vitamin D receptor.

Authors:  Takuya Mohri; Miki Nakajima; Shingo Takagi; Sayaka Komagata; Tsuyoshi Yokoi
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

10.  Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4.

Authors:  Shingo Takagi; Miki Nakajima; Takuya Mohri; Tsuyoshi Yokoi
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

View more
  55 in total

Review 1.  MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.

Authors:  Ai-Ming Yu; Ye Tian; Mei-Juan Tu; Pui Yan Ho; Joseph L Jilek
Journal:  Drug Metab Dispos       Date:  2015-11-13       Impact factor: 3.922

2.  Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.

Authors:  Douglas F Dluzen; Dongxiao Sun; Anna C Salzberg; Nate Jones; Ryan T Bushey; Gavin P Robertson; Philip Lazarus
Journal:  J Pharmacol Exp Ther       Date:  2014-01-07       Impact factor: 4.030

3.  Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport.

Authors:  Magnus Ingelman-Sundberg; Xiao-Bo Zhong; Oliver Hankinson; Sudheer Beedanagari; Ai-Ming Yu; Lai Peng; Yoichi Osawa
Journal:  Drug Metab Dispos       Date:  2013-08-05       Impact factor: 3.922

Review 4.  Complexity of microRNA function and the role of isomiRs in lipid homeostasis.

Authors:  Kasey C Vickers; Praveen Sethupathy; Jeanette Baran-Gale; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-03-15       Impact factor: 5.922

Review 5.  The effects of microRNA on the absorption, distribution, metabolism and excretion of drugs.

Authors:  Y He; J R Chevillet; G Liu; T K Kim; K Wang
Journal:  Br J Pharmacol       Date:  2014-12-01       Impact factor: 8.739

6.  Systems genetics identifies a co-regulated module of liver microRNAs associated with plasma LDL cholesterol in murine diet-induced dyslipidemia.

Authors:  Alisha R Coffey; Tangi L Smallwood; Jody Albright; Kunjie Hua; Matt Kanke; Daniel Pomp; Brian J Bennett; Praveen Sethupathy
Journal:  Physiol Genomics       Date:  2017-09-15       Impact factor: 3.107

7.  Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach.

Authors:  Ioannis Papageorgiou; Michael H Court
Journal:  Biochem Pharmacol       Date:  2017-04-19       Impact factor: 5.858

Review 8.  MicroRNAs and Noncoding RNAs in Hepatic Lipid and Lipoprotein Metabolism: Potential Therapeutic Targets of Metabolic Disorders.

Authors:  Neetu Sud; Jennifer Taher; Qiaozhu Su
Journal:  Drug Dev Res       Date:  2015-08-19       Impact factor: 4.360

9.  IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs.

Authors:  Jie-Mei Wang; Yining Qiu; Zhao Yang; Hyunbae Kim; Qingwen Qian; Qinghua Sun; Chunbin Zhang; Lei Yin; Deyu Fang; Sung Hong Back; Randal J Kaufman; Ling Yang; Kezhong Zhang
Journal:  Sci Signal       Date:  2018-05-15       Impact factor: 8.192

10.  Noncoding microRNAs: small RNAs play a big role in regulation of ADME?

Authors:  Ai-Ming Yu; Yu-Zhuo Pan
Journal:  Acta Pharm Sin B       Date:  2012-03-31       Impact factor: 11.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.